50 cancer patients will take part in the first phase of clinical trials of the Russian cancer vaccine. According to Mash, applications for participation are closed – there were more than 6 thousand in total.
The Herzen Moscow Research Oncology Institute told us: the commission has already begun selecting participants; preference will be given to cancer patients who have already undergone treatment – chemoradiotherapy and other therapies, as well as surgery. With sufficient immunity for the experiment. The first stage of the program will last until the end of 2025, during which time the trial participants will be under constant medical supervision to check the drug for safety and select the correct dosage.
They promise to invite more people to the second phase to study the effect of the oncology vaccine on different types of cancer. It is expected that at the final stage of testing the drug will be combined with other treatment methods. But they warn: you shouldn’t expect a magic pill for cancer anytime soon. Testing the vaccine will take at least 9 years.
❗️Subscribe to Mash
